Helocyte
Mr. Taffy serves as a member of the Board of Directors of Helocyte, a position he has held since June of 2015. He previously served as their founding President and Chief Executive Officer until September of 2021. Mr. Taffy has over twenty years of experience in life sciences corporate development and business operations. He identified the Helocyte programs and co-founded the company during his role as Entrepreneur in Residence at Fortress Biotech. Mr. Taffy previously held the positions of Head (Senior Director) of Business Affairs at Forest Labs (now Allergan Plc) and Director of Corporate Development at Life Technologies (now Thermo Fisher Scientific), where he also held Board positions on behalf of the company. He also previously served as Vice President and General Counsel of Paramount Biosciences LLC, a global healthcare investment firm, where he led the formation and interim operation of a number of portfolio companies. Mr. Taffy started his career as Counsel for Intellectual Property at The Procter and Gamble Company. He holds a B.A. in biochemistry from the University of North Texas and a J.D. from Syracuse University College of Law.
This person is not in any teams
This person is not in any offices
Helocyte
Helocyte is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapies for the prevention and treatment of cancer and infectious disease (in particular, cytomegalovirus or “CMV”)